374 related articles for article (PubMed ID: 27615014)
1. Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment.
Kim MG; Shon Y; Kim J; Oh YK
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27615014
[TBL] [Abstract][Full Text] [Related]
2. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
Shim G; Kim JY; Han J; Chung SW; Lee S; Byun Y; Oh YK
J Control Release; 2014 Sep; 189():80-9. PubMed ID: 24973719
[TBL] [Abstract][Full Text] [Related]
3. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
[TBL] [Abstract][Full Text] [Related]
4. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery.
Miao W; Shim G; Kang CM; Lee S; Choe YS; Choi HG; Oh YK
Biomaterials; 2013 Dec; 34(37):9638-47. PubMed ID: 24016852
[TBL] [Abstract][Full Text] [Related]
5. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
6. Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
Watanabe S; Noma K; Ohara T; Kashima H; Sato H; Kato T; Urano S; Katsube R; Hashimoto Y; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
Cancer Biol Ther; 2019; 20(9):1234-1248. PubMed ID: 31185791
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
8. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
[TBL] [Abstract][Full Text] [Related]
9. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
[TBL] [Abstract][Full Text] [Related]
10. Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.
Zhen Z; Tang W; Wang M; Zhou S; Wang H; Wu Z; Hao Z; Li Z; Liu L; Xie J
Nano Lett; 2017 Feb; 17(2):862-869. PubMed ID: 28027646
[TBL] [Abstract][Full Text] [Related]
11. [FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.].
Pleshkan VV; Alekseenko IV; Tyulkina DV; Kyzmich AI; Zinovyeva MV; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2016; 34(3):90-97. PubMed ID: 30383930
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
Lai D; Ma L; Wang F
Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695
[TBL] [Abstract][Full Text] [Related]
13. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
[TBL] [Abstract][Full Text] [Related]
14. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
Zheng XT; Ma XQ; Li CM
J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Akai M; Noma K; Kato T; Nishimura S; Matsumoto H; Kawasaki K; Kunitomo T; Kobayashi T; Nishiwaki N; Kashima H; Kikuchi S; Ohara T; Tazawa H; Choyke PL; Kobayashi H; Fujiwara T
Br J Cancer; 2024 Jun; 130(10):1647-1658. PubMed ID: 38555315
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
[TBL] [Abstract][Full Text] [Related]
17. The application of the fibroblast activation protein α-targeted immunotherapy strategy.
Jiang GM; Xu W; Du J; Zhang KS; Zhang QG; Wang XW; Liu ZG; Liu SQ; Xie WY; Liu HF; Liu JS; Wu BP
Oncotarget; 2016 May; 7(22):33472-82. PubMed ID: 26985769
[TBL] [Abstract][Full Text] [Related]
18. Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents.
Roy J; Hettiarachchi SU; Kaake M; Mukkamala R; Low PS
Theranostics; 2020; 10(13):5778-5789. PubMed ID: 32483418
[No Abstract] [Full Text] [Related]
19. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
20. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer.
Miao W; Shim G; Lee S; Lee S; Choe YS; Oh YK
Biomaterials; 2013 Apr; 34(13):3402-10. PubMed ID: 23380350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
